RELATING TO INSURANCE -- ACCIDENT AND SICKNESS INSURANCE POLICIES
Impact
The enactment of S2877 will significantly reduce out-of-pocket expenses for individuals with diabetes who rely on insulin and related medical supplies. By ensuring that these essential items are more affordable, it seeks to improve compliance with treatment regimens among patients, who might otherwise face financial barriers to obtaining necessary care. This law can also lead to improved public health outcomes through better management of diabetes across the population.
Summary
S2877 aims to amend existing laws related to health insurance coverage for diabetes treatment in Rhode Island. The bill mandates that all individual and group health insurance policies providing medical coverage must include specific treatments and supplies for diabetes, including equipment for insulin administration and glucose monitoring. Importantly, it caps the amount a covered individual must pay at no more than $25 for a supply lasting 30 days, or for equipment designed for longer use, while simultaneously eliminating any deductible requirements for these items. This provision is set to take effect on January 1, 2027.
Contention
While the bill addresses critical healthcare needs, it has generated discussions regarding the potential economic implications for health insurance providers and the state's budget. Critics may argue that capping costs and eliminating deductibles could lead to increased premiums in the long term. Additionally, there could be concern over how new insurance mandates might affect the overall market for health insurance within the state, particularly in terms of cost-sharing structures that balance risks among insured individuals.
Caps amount payable for 30 day supply of equipment/supplies for insulin administration/glucose monitoring at $25 or equipment designed to last more than 30 days with no deductible commencing January 1, 2026.
Caps amount payable for 30 day supply of equipment/supplies for insulin administration/glucose monitoring at $25 or equipment designed to last more than 30 days with no deductible commencing January 1, 2026.
Mandates all insurance contracts, plans or policies provide insurance coverage for the expense of diagnosing and treating infertility, for women between the ages of 25 and 42 years including preimplantation genetic diagnosis (PGD) in conjunction with IVF.
Requires health insurance plans to cover services provided by licensed certified professional midwives. Insurers must report utilization and cost data annually. Certain limited benefit policies are exempt.